Aclarion, Inc. (ACONW)

↓ Download CSV

CIK 0001635077 · Nasdaq · Services-Medical Laboratories

  • Sector Services
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Aclarion, Inc. reported revenue of $75.7K, up 65.6% from the prior year. The company ran a net loss, with a net margin of -9551.9% and a gross margin of 9.0%. It held $13.67M in total assets against $837.3K in total liabilities.

Key ratios (FY2025)

9.0%
Gross margin
-9312.5%
Operating margin
-9551.9%
Net margin
-56.4%
Return on equity
+65.6%
Revenue growth (YoY)
Metric (FY)202520242023202220212020
Revenue$75.7K$45.7K$75.4K$60.4K$60.3K
Cost of Revenue$68.9K$84.7K$75.7K$65.3K$69.2K
Gross Profit$6.8K-$38.9K-$324-$4.9K-$8.9K
Operating Income-$7.05M-$5.51M-$4.88M-$5.56M-$2.95M
Net Income-$7.23M-$6.99M-$4.91M-$7.07M-$4.95M
EPS (Diluted)$-13.61$-7478.90$-79782.00$-19.61$-6.58
Total Assets$13.67M$2.12M$2.46M$2.91M$1.89M
Total Liabilities$837.3K$1.15M
Shareholders' Equity$12.84M$970.1K-$728.0K$2.23M-$12.83M-$7.08M
Cash & Equivalents$12.02M$453.7K$1.02M$1.47M$432.5K
Operating Cash Flow-$7.16M-$5.27M-$3.65M-$4.95M-$2.40M
Capital Expenditures$21.5K$5.1K$0
Shares Outstanding854.4K1.4K825.5K491.3K905.7K